This is a limited company view. Sign up for a Free Trial to see everything.

Akebia Therapeutics is a biopharmaceutical company and global leader in developing therapies using hypoxia inducible factor (HIF) to treat serious disease.

B2B
Biotechnology
Healthcare
Pharmaceuticals

Overview

Location

Boston

Founded

2007

Employees

116

Stage

Public

Total funding

$83M

Last funding

5 years ago

Acquisitions

0

Growth score

0

Mindshare score

-109

Scoring

Employee Growth

Use Akebia Therapeutics's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use Akebia Therapeutics's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

President and CEO
Clinical Project Manager
SVP, Corporate Communications and Investor Relations
Sr Director QA, Head of Quality
Associate Director Clinical Operations
Director Clinical Operations
Manager, Corporate Communications & Social Media
Manager, Quality Assurance
IT Manager
Director Drug Safety & Pharmacovigilance Operations
Senior Manager, Program Management
Senior Director Information Technology
Senior Director, Clinical Development/Medical Research
Senior Director, Alliance Management
Director Toxicology & DMPK
Director
Sr. Director CMC
Director
Associate Director, Regulatory Affairs

Similar Companies

Innovative Biologics

Innovative Biologics is an anti-infective drug discovery and development company targeting microbes that produce pore-forming toxins.
Unknown|2 employees

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes